Andrew Newland
Newland, 56, is founder and chief executive of Angle, which produces a medical device that can detect cancer cells in the blood. After a career at KPMG he moved onto the board of biotechs before launching Angle, based in Guildford.
Newland, 56, is founder and chief executive of Angle, which produces a medical device that can detect cancer cells in the blood. After a career at KPMG he moved onto the board of biotechs before launching Angle, based in Guildford.
